Sign In
Buy LH
$258.92
+1.22 (+0.473%)
At Close: Jun 03, 2026
Should You Continue to Hold LH Stock in Your Portfolio?
08:55am, Tuesday, 02'nd Dec 2025
Labcorp expands in specialty testing and ramps up acquisitions, but macro pressures and currency headwinds complicate its growth outlook.
Boston Family Office LLC Acquires New Holdings in Labcorp Holdings Inc. $LH
05:12am, Tuesday, 02'nd Dec 2025
Boston Family Office LLC bought a new position in Labcorp Holdings Inc. (NYSE: LH) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. T
Labcorp Holdings Inc. $LH Position Cut by Brandes Investment Partners LP
04:36am, Tuesday, 02'nd Dec 2025
Brandes Investment Partners LP reduced its holdings in Labcorp Holdings Inc. (NYSE: LH) by 57.6% during the undefined quarter, according to the company in its most recent filing with the Securities an
Advisors Asset Management Inc. Buys 770 Shares of Labcorp Holdings Inc. $LH
03:14am, Monday, 01'st Dec 2025
Advisors Asset Management Inc. grew its stake in Labcorp Holdings Inc. (NYSE: LH) by 19.4% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commis
Labcorp (LH) Up 8.1% Since Last Earnings Report: Can It Continue?
12:31pm, Thursday, 27'th Nov 2025
Labcorp (LH) reported earnings 30 days ago. What's next for the stock?
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 25'th Nov 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Labcorp Appoints Victor Bulto to Board of Directors
08:30am, Monday, 24'th Nov 2025
Bulto, President, U.S. of Novartis, brings global healthcare leadership and growth track record to support Labcorp's long-term strategy BURLINGTON, N.C., Nov. 24, 2025 /PRNewswire/ -- Labcorp (NYSE:
Cetera Investment Advisers Lowers Stock Position in Labcorp Holdings Inc. $LH
04:38am, Monday, 24'th Nov 2025
Cetera Investment Advisers lessened its holdings in Labcorp Holdings Inc. (NYSE: LH) by 1.3% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Ex
LH Shares Gain Following Publication of New Plasma Detect MRD Data
09:16am, Friday, 21'st Nov 2025
Labcorp shares edge higher as new studies spotlight Plasma Detect's role in tracking MRD and improving post-surgery cancer detection.
Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research
07:04am, Wednesday, 19'th Nov 2025
Studies demonstrate Labcorp Plasma Detect MRD Technology can inform treatment strategies and advance cancer research BURLINGTON, N.C. , Nov. 19, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global le
Lunit and Labcorp Announce Strategic Collaboration to Advance AI-Powered Digital Pathology Research
09:00am, Monday, 17'th Nov 2025
DURHAM, N.C. and SEOUL, South Korea , Nov. 17, 2025 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader of innovative and compre
World Investment Advisors Takes Position in Labcorp Holdings Inc. $LH
03:47am, Wednesday, 05'th Nov 2025
World Investment Advisors purchased a new stake in shares of Labcorp Holdings Inc. (NYSE: LH) during the second quarter, according to the company in its most recent filing with the Securities and Exch
Labcorp Positioned For Gradual Upside With Resilient Margins And Dividend Support
02:45pm, Tuesday, 28'th Oct 2025
Laboratory Corp (NYSE: LH) reported third-quarter 2025 adjusted earnings per share of $4.18 on Tuesday, up from $3.50 a year ago, beating the consensus of $4.18.
Labcorp Holdings Inc. (LH) Q3 2025 Earnings Call Transcript
12:31pm, Tuesday, 28'th Oct 2025
Labcorp Holdings Inc. (NYSE:LH ) Q3 2025 Earnings Call October 28, 2025 9:00 AM EDT Company Participants Christin O'Donnell - Vice President of Investor Relations Adam Schechter - President, CEO & Cha
LH Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down
11:06am, Tuesday, 28'th Oct 2025
Labcorp's Q3 earnings beat forecasts and margins improve, but a trimmed 2025 sales outlook sends shares down.
